InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Monday, 08/28/2017 2:01:50 PM

Monday, August 28, 2017 2:01:50 PM

Post# of 807
As previously reported, BTIG upgraded Juno Therapeutics to Neutral from Sell. Analyst Dane Leone said Gilead's (GILD) acquisition of Kite Pharma (KITE) will raise valuations across the CAR T space due to a scarcity effect of remaining players.